Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

CITEDBY Reports

  1. Yousra M El-Far, Mahmoud M Zakaria, Mahmoud M Gabr, Amal M El Gayar, Ibrahim M El-Sherbiny, Laila A Eissa, . A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes. Nanomedicine, 2016; 11(19): 2581.
    Crossref
  2. Christopher J. Cheng, Gregory T. Tietjen, Jennifer K. Saucier-Sawyer, W. Mark Saltzman, . A holistic approach to targeting disease with polymeric nanoparticles. Nature Reviews Drug Discovery, 2015; 14(4): 239.
    Crossref
  3. Chih-Hung Lin, Chun-Han Chen, Zih-Chan Lin, Jia-You Fang, . Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. Journal of Food and Drug Analysis, 2017; 25(2): 219.
    Crossref
  4. Francisca Araújo, Neha Shrestha, Mohammad-Ali Shahbazi, Dongfei Liu, Bárbara Herranz-Blanco, Ermei M. Mäkilä, Jarno J. Salonen, Jouni T. Hirvonen, Pedro L. Granja, Bruno Sarmento, Hélder A. Santos, . Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs. ACS Nano, 2015; 9(8): 8291.
    Crossref
  5. Pik-Ling Lam, Wai-Yeung Wong, Zhaoxiang Bian, Chung-Hin Chui, Roberto Gambari, . Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Nanomedicine, 2017; 12(4): 357.
    Crossref
  6. Sara Pistone, Dafina Qoragllu, Gro Smistad, Marianne Hiorth, . Formulation and preparation of stable cross-linked alginate–zinc nanoparticles in the presence of a monovalent salt. Soft Matter, 2015; 11(28): 5765.
    Crossref